Cargando…
TLR2/6 signaling promotes the expansion of premalignant hematopoietic stem and progenitor cells in the NUP98-HOXD13 mouse model of MDS
Toll-like receptor 2 (TLR2) expression is increased on hematopoietic stem and progenitor cells (HSPCs) of patients with myelodysplastic syndromes (MDS), and enhanced TLR2 signaling is thought to contribute to MDS pathogenesis. Notably, TLR2 heterodimerizes with TLR1 or TLR6, and while high TLR2 is a...
Autores principales: | Monlish, Darlene A., Greenberg, Zev J., Bhatt, Sima T., Leonard, Kathryn M., Romine, Molly P., Dong, Qian, Bendesky, Lauren, Duncavage, Eric J., Magee, Jeffrey A., Schuettpelz, Laura G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7673652/ https://www.ncbi.nlm.nih.gov/pubmed/32652111 http://dx.doi.org/10.1016/j.exphem.2020.07.001 |
Ejemplares similares
-
Progressive Genomic Instability in the Nup98-HoxD13 Model of MDS Correlates with Loss of the PIG-A Gene Product()()
por: Byrne, Michael, et al.
Publicado: (2014) -
The Role of Toll-Like Receptors in Hematopoietic Malignancies
por: Monlish, Darlene A., et al.
Publicado: (2016) -
Systemic TLR2 agonist exposure regulates hematopoietic stem cells via cell-autonomous and cell-non-autonomous mechanisms
por: Herman, A C, et al.
Publicado: (2016) -
Thymic precursor cells generate acute myeloid leukemia in NUP98-PHF23/NUP98-HOXD13 double transgenic mice
por: Kundu, Subhadip, et al.
Publicado: (2019) -
p300 suppresses leukemia development in NUP98-HOXD13 driven myelodysplastic syndrome
por: Man, Na, et al.
Publicado: (2018)